Evonik Industries and OPX Biotechnologies to Develop Bio-Based Chemicals
May 14, 2013
Agreement calls for OPXBIO to use its EDGE (Efficiency Directed Genome Engineering) technology to develop the bio-processes.
OPX Biotechnologies, Inc. (OPXBIO) and Evonik Industries AG announced May 14 that the two companies have entered into an agreement to jointly develop certain bio-based specialty chemicals. The joint-development agreement calls for OPXBIO to use its EDGE (Efficiency Directed Genome Engineering) technology to develop the bio-processes.
“The bio-process we’re developing has the potential to create economic and sustainable versions of products we use in our everyday lives,” said Charles Eggert, OPXBIO president and CEO.
According to the agreement, OPXBIO will also be able to market bio-based products resulting from the Evonik collaboration.
Many facilities handle dangerous processes and products on a daily basis. Keeping everything under control demands well-trained people working with the best equipment.
Enhance the training experience and increase retention by training hands-on in Emerson's Interactive Plant Environment. Build skills here so you have them where and when it matters...
See how Rosemount™ 625IR Fixed Gas Detector helps keep workers safe with ultra-fast response times to detect hydrocarbon gases before they can create dangerous situations.
